STOCKHOLDERS' EQUITY (Details Textual) (USD $)	1 Months Ended	6 Months Ended							12 Months Ended	1 Months Ended	6 Months Ended
	Apr. 30, 2013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 William R. Doyle [Member]	Jun. 30, 2013 Subsequent Event [Member]	Jun. 30, 2013 Subsequent Event [Member] Kiron Clinical Sleep Lab LLC [Member]	Jun. 30, 2013 Preferred Stock [Member]	Jun. 30, 2013 Preferred Stock [Member] Subsequent Event [Member]	Dec. 31, 2012 Private Placement [Member]	Apr. 30, 2013 Private Placement [Member] Common Stock [Member]	Jun. 30, 2013 Private Placement [Member] Common Stock [Member]	Jun. 30, 2013 Private Placement [Member] Warrant [Member] Issue One [Member]	Jun. 30, 2013 Private Placement [Member] Preferred Stock [Member]	May 02, 2013 Private Placement [Member] Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues (in shares)				133,333	239,733			19,711	4,433,333	400,000	20,000	20,000
Stock Issued During Period, Shares, Issued for Services (in shares)		200,000			3,300,000
Stock Issued During Period, Value, Issued for Services		$ 40,000
Deferred Compensation Arrangement, Share-Based Payments, Amortization Of Compensation Expense		60,000	90,000
Proceeds from Issuance of Private Placement	30,000	5,000
Stock Issued During Period Price Per Share										$ 0.075	$ 0.25	$ 0.35
Sale Of Stock, Shares Authorized To Sell (in shares)														200,000
Preferred Stock, Dividend Rate, Percentage		10.00%
Sale of Stock, Price Per Share														$ 10.00
Development Stage Entities, Stock Issued, Value, Issued for Cash													2,000,000
Preferred Stock, Redemption Price Per Share													$ 0.075
Convertible Preferred Stock, Conversion Percentage		5.00%
Net Proceeds From Issuance Of Preferred Stock					197,110
Debt Conversion, Converted Instrument, Shares Issued (in shares)							10,374
Convertible Notes Payable								$ 103,740
Stock Issued During Period, Shares, Acquisitions (in shares)						727,434
Class of Warrant or Right, Outstanding (in shares)					429,000